The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)

Conditions:   B-cell Acute Lymphoblastic Leukemia (B-ALL);   Safety and Efficacy of CD19 UCAR-T Cells Intervention:   Biological: CD19 UCARTcells Sponsor:   Shanghai Longyao Biotechnology Inc., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials